Theca Lutein Cells represent a distinctive type of cells that emerge during the luteal phase of the menstrual cycle or in the corpus luteum of pregnancy. Originating from the theca interna cells surrounding the developing ovarian follicle, theca lutein cells undergo transformations under the influence of luteinizing hormone (LH). These cells play a crucial role in the production of progesterone, a hormone vital for maintaining pregnancy. Theca lutein cells, along with granulosa lutein cells, constitute the corpus luteum, a temporary endocrine structure formed after ovulation. Progesterone produced by theca lutein cells helps prepare the endometrium for potential embryo implantation and maintains a supportive environment for early pregnancy. In conditions such as gestational trophoblastic disease, ovarian hyperstimulation syndrome, or multiple pregnancies, the ovaries can develop multiple corpora lutea, leading to an excessive production of progesterone and its metabolites. Understanding the functions of theca lutein cells is crucial for comprehending reproductive physiology and addressing conditions related to hormonal imbalances. Research in this area contributes to advancements in reproductive medicine, fertility treatments, and the management of disorders affecting the corpus luteum. Ongoing studies aim to uncover the molecular mechanisms governing theca lutein cell function and their impact on reproductive health.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy